These results suggest that instead of activating novel signaling pathways, FLT3 utilizes components of BCR signaling pathway to promote proliferation and survival of lymphoid cells in B cells acute lymphoblastic leukemia. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.